Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Sana Biotechnology, Inc. (SANA : NSDQ)

• Company Description    Sana Biotechnology Inc. is focused on creating and delivering engineered cells as medicines for patients. The company involved in repairing and controlling genes, replacing missing or damaged cells as well as making its therapies. Sana Biotechnology Inc. is based in SEATTLE. Number of Employees: 194

• Price / Volume Information    Yesterday's Closing Price: $2.83 Daily Weekly Monthly 20 Day Moving Average: 4,877,063 shares Shares Outstanding: 225.48 (millions) Market Capitalization: $638.10 (millions) Beta: 1.86 52 Week High: $7.40 52 Week Low: $1.26 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 20.94% 16.50% 12 Week 111.19% 69.79% Year To Date 73.62% 64.76%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 188 EAST BLAINE STREET SUITE 400 - SEATTLE,WA 98102 USA ph: 206-701-7914 fax: - investor.relations@sana.com http://www.sana.com

• General Corporate Information    Officers Steven D. Harr - President; Chief Executive Officer and Director Hans E. Bishop - Chairman Susan Wyrick - Acting Chief Financial Officer Douglas Cole - Director Richard Mulligan - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 799566104 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/14/25 Share - Related Items Shares Outstanding: 225.48 Most Recent Split Date: (:1) Beta: 1.86 Market Capitalization: $638.10 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.20 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.76 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 23.96% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/14/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.05 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 37.50% vs. Previous Quarter: 13.04% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - -86.58 12/31/24 - -82.16 ROA 06/30/25 - - 03/31/25 - -44.49 12/31/24 - -43.78 Current Ratio 06/30/25 - - 03/31/25 - 3.40 12/31/24 - 3.54 Quick Ratio 06/30/25 - - 03/31/25 - 3.40 12/31/24 - 3.54 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 0.93 12/31/24 - 1.12 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©